SCHEMBL6286151

SCHEMBL6286151

COc1ccc(-c2cc3cnccc3[nH]2)cc1C(N)=O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IKBKB O14920 1/20 0.47
CHUK O15111 1/20 0.47
CDC7 O00311 6/20 0.47
MKNK1 Q9BUB5 1/20 0.46
MKNK2 Q9HBH9 1/20 0.46
CLK1 P49759 3/20 0.46
CDK5 Q00535 3/20 0.46
DYRK1A Q13627 3/20 0.46
CDK5R1 Q15078 3/20 0.46
CLK2 P49760 1/20 0.46
CLK3 P49761 1/20 0.46
CLK4 Q9HAZ1 1/20 0.46
DYRK1B Q9Y463 1/20 0.46
PARP1 P09874 3/20 0.45
JAK2 O60674 1/20 0.44
ACVR1 Q04771 1/20 0.43
KDM4E B2RXH2 1/20 0.43
ALDH1A1 P00352 1/20 0.43
HPGD P15428 1/20 0.43
F3 P13726 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6282531 0.91 IKBKB (0.47) IKBKBCHUKCDC7MKNK1MKNK2
SCHEMBL6286918 0.87 PARP1 (0.47) IKBKBCHUKCDC7MKNK1MKNK2
SCHEMBL6286157 0.82 KDM4E (0.44) CHUKDYRK1ACLK2CLK3KDM4E
SCHEMBL6278566 0.81 RIPK1 (0.45) IKBKBCHUKCDC7MKNK1MKNK2
SCHEMBL6286700 0.79 RIPK1 (0.65)
SCHEMBL6286410 0.79 PARP1 (0.42) CHUKCDC7MKNK1MKNK2PARP1
SCHEMBL6493580 0.79 JAK2 (0.45) CDC7PARP1JAK2ACVR1
SCHEMBL6287143 0.78 ALDH1A1 (0.72) PARP1KDM4EALDH1A1HPGD
SCHEMBL6286089 0.78 ACVR1 (0.42) IKBKBCHUKCDC7MKNK1MKNK2
SCHEMBL6287771 0.77 PARP1 (0.47) CHUKCDC7MKNK1MKNK2PARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6943174-B2 6,5-Fused bicyclic heterocycles WARNER-LAMBERT COMPANY (US) 2005-09-13 US claimed
US-20040014759-A1 6,5-Fused bicyclic heterocycles PICARD JOSEPH ARMAND (US) 2004-01-22 US claimed
US-6943174-B2 6,5-Fused bicyclic heterocycles WARNER-LAMBERT COMPANY (US) 2005-09-13 US disclosed
EP-1294718-A2 6,5-FUSED BICYCLIC HETEROCYCLES WARNER-LAMBERT COMPANY LLC (US) 2003-03-26 EP disclosed
WO-2001096336-A2 6,5-FUSED BICYCLIC HETEROCYCLES WARNER-LAMBERT COMPANY (US) 2001-12-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040014759-A1 6,5-Fused bicyclic heterocycles ALOX15, ALOX5, ALOX15B IKBKB 678/4885CHUK 301/4885CDC7 3702/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.